Archive · 24 Jul 2025
India to Enhance HIV Care with Local Centers, Digital Tracking
The Indian government is making it easier for people with HIV to get the medicine they need.
They're opening local centers where people can pick up their medicine instead of traveling far.
They're also using a new app to keep track of everyone and make sure they get the care they need.
The goal is to eliminate HIV as a public health threat by 2030 by ensuring that people can get treatment and support easily.
They're also focused on stopping the spread of HIV from mothers to their babies.
This approach will include providing comprehensive care and tackling issues such as social stigma.
India's health ministry plans to bring HIV treatment to over 2.5 million people by 2030.
New guidelines emphasize a person-centered approach and aim to eliminate HIV as a public health threat.
Mobile applications like NACO-CSC will digitize data and improve patient tracking and monitoring.
Community-based link ART centres (LACs) will allow patients to access ARV medicines locally.
The program includes focus on preventing mother-to-child transmission and managing HIV-related health issues.
- Who
- The Union health ministry and the National AIDS Control Organisation (NACO) are involved.
- What
- The Union health ministry is overhauling its approach to HIV treatment and support.
- When
- The changes are being implemented with a goal to eradicate AIDS by 2030.
- Where
- In India.
- Why
- To make HIV treatment more accessible, improve patient care, and eliminate HIV as a public health threat.
Challenges
Solutions
HIV Treatment
Challenges
Challenges exist in linking 95% of HIV infected Individuals to ART services.
Solutions
Government plans to establish more Care and Support Centres and mobile app to tackle the issues.
- Estimated People Living with HIV
- 2.54 million (2023)
- Deaths Related to AIDS (2023)
- 35,870
- Focus
- Elimination of Vertical Transmission of HIV & Syphilis (EVTHS)
- Mobile App
- NACO-CSC
- Key Drug Manufacturers
- Cipla, Aurobindo Pharma, Zydus Lifesciences, Lupin
- Market Value of HIV Drugs (2022)
- $250.23 million
- Projected Market Value of HIV Drugs (2030)
- $389.90 million